Form 4 for OMCL OMNICELL, INC.
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-08 · accession 0001415889-25-007669 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-11 | 2025-03-08 | OMCL | Manley Corey J | EVP, CHIEF LEGAL, ADMIN Off | A - Grant | $0.00 | +56.3K | 102.6K | +121% | $0 | |
| 2025-03-11 | 2025-03-08 | OMCL | Manley Corey J | EVP, CHIEF LEGAL, ADMIN Off | F - Tax | $36.99 | -4,697 | 97.9K | -5% | -$173.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-08 | A | A | 56,268 | $0.00 | 102,604 | D | — | — | (F1) Reflects performance-based restricted stock units that were previously granted on February 27, 2024, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 8, 2025 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 56,268 performance-based restricted stock units (176% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively). |
| 2 | Common | Common Stock | 2025-03-08 | F | D | 4,697 | $36.99 | 97,907 | D | — | — | (F2) Reflects withholding of shares to cover taxes due in connection with the vesting of performance-based restricted stock units |